1. Home
  2. NSYS vs PULM Comparison

NSYS vs PULM Comparison

Compare NSYS & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nortech Systems Incorporated

NSYS

Nortech Systems Incorporated

N/A

Current Price

$6.94

Market Cap

22.3M

Sector

Technology

ML Signal

N/A

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

HOLD

Current Price

$4.08

Market Cap

18.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSYS
PULM
Founded
1981
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3M
18.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NSYS
PULM
Price
$6.94
$4.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.8K
5.4K
Earning Date
11-13-2025
10-16-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$116,672,000.00
$3,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$134.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.50
$3.90
52 Week High
$12.40
$10.40

Technical Indicators

Market Signals
Indicator
NSYS
PULM
Relative Strength Index (RSI) 35.24 33.89
Support Level $6.76 $4.32
Resistance Level $7.05 $4.67
Average True Range (ATR) 0.18 0.29
MACD 0.03 -0.04
Stochastic Oscillator 28.96 16.66

Price Performance

Historical Comparison
NSYS
PULM

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: